Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3).
1. In rat striatal membranes, muscarinic toxin 3 (MT3), a selective ligand of the cloned m4 receptor subtype, antagonized the acetylcholine (ACh) inhibition of forskolin- and dopamine D1 receptor-stimulated adenylyl cyclase activities with pA2 values of 8.09 and 8.15, respectively. 2. In radioligand binding experiments, MT3 increased the Kd but did not change the Bmax value of [3H]-N-methylscopolamine (3H]-NMS) binding to rat striatal muscarinic receptors. The toxin displaced the major portion of the [3H]-NMS binding sites with a Ki of 8.0 nM. 3. In rat myocardium, MT3 antagonized the ACh inhibition of adenylyl cyclase with a Ki value of 860 nM. 4. In rat cerebral cortical membranes prelabelled with [3H]-myo-inositol, MT3 counteracted the methacholine stimulation of [3H]-inositol phosphates formation with a Ki value of 113 nM. 5. The present study shows that MT3 is a potent antagonist of the striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity. This finding provides strong evidence for the classification of these receptors as pharmacologically equivalent to the m4 gene product (M4). On the other hand, the weaker potencies of MT3 in antagonizing the muscarinic responses in cerebral cortex and in the heart are consistent with the reported lower affinities of the toxin for the cloned m1 and m2 receptor subtypes, respectively.
Olianas
M C
MC
Department of Neurosciences, University of Cagliari, Italy.
Adem
A
A
Karlsson
E
E
Onali
P
P
D000109:Acetylcholine / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D005576:Colforsin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004789:Enzyme Activation; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000096:biosynthesis; D036341:Intercellular Signaling Peptides and Proteins; D008024:Ligands; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D043588:Receptor, Muscarinic M4; D017447:Receptors, Dopamine D1 / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000378:metabolism*; D014316:Tritium
D000067956:Adenylyl Cyclase Inhibitors; D007295:Inositol Phosphates; D036341:Intercellular Signaling Peptides and Proteins; D008024:Ligands; D018727:Muscarinic Antagonists; D010455:Peptides; D043588:Receptor, Muscarinic M4; D017447:Receptors, Dopamine D1; D011976:Receptors, Muscarinic; C089528:muscarinic toxin 3; D016210:Methacholine Chloride; D014316:Tritium; D005576:Colforsin; D000262:Adenylyl Cyclases; D000109:Acetylcholine